http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5603963-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81ba2c4156354c844d4a8883be561f00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-242 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-242 |
| filingDate | 1994-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1997-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f46bbca5bc8eb76cc833a3edf4412f99 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eeef99bb4d949a3062867ff5f1b3d96a |
| publicationDate | 1997-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-5603963-A |
| titleOfInvention | Method for the treatment of retroviral diseases such as acquired immune deficiency syndrome utilizing (pseudo)halogen complexes of gold(1) |
| abstract | A method of treating retroviral diseases such as AIDS in an infected host is provided. The method comprises administering a therapeutically effective amount of at least one (pseudo)halogen complex of gold(I) in a pharmaceutically acceptable carrier. The (pseudo)halogen complex in gold(I) can be chosen from the group consisting of:R-Au-[CN], R-Au-[SCN], and R-Au-[SeCN].R may be chosen from the group consisting of: phosphines (such as triethylphosphine); halogens (such as chlorine); and pseudohalogens (such as an additional cyano, thiocyanato or selenocyanato moiety). When R is an additional cyano moiety, the complex is termed a dicyanogold(I) complex, i.e., [Au(CN)2]-, and is preferably employed as an alkali, ammonium or alkaline earth salt. When R is another moiety, the complex may be either neutral or anionic in nature, and any anionic complexes are also preferably present as alkali, ammonium or alkaline earth salts. Suitable complexes include: chlorogold(I) cyanide, triethylphosphinegold(I) cyanide, and dicyanogold(I). |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019008013-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11548792-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010218491-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010215897-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004063681-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022171883-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022171883-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004024146-A1 |
| priorityDate | 1994-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 126.